Infants and children who are at particular risk of contracting the serious infection called meningitis should receive a vaccine at an early age and receive routine vaccinations through their college-aged years, according to an updated recommendation from the American Academy of Pediatrics, the largest organization of pediatricians in the United States.
The update is the first time the group has made a statement on "meningococcal" vaccines since 2011, and it notes that since its last update, three such vaccines have been approved for use in infants. Though the guidelines don't urge the vaccines for every young child (the current standard of care is to begin vaccination at age 11), they do recommend early vaccination for children aged 2 months and older who have immune deficiencies, are missing spleens, or have sickle cell disease or other higher infection risks.
"We needed to have new recommendations so that pediatricians would understand how to use these vaccines in young infants and children, since they're now available," said guidelines author Dr. Michael Brady, associate medical director at Nationwide Children's Hospital in Columbus, Ohio.
"We're telling pediatricians that we don't feel it's necessary to give this vaccination routinely to young children," he added, "but for children with select risks, it's a good vaccine to give."
The updated meningococcal recommendations are published online July 28 in the journal Pediatrics.
Meningococcal disease is linked to a variety of infections, including meningitis and pneumonia. Meningitis, an infection of the covering of the brain and spinal cord, strikes between 800 and 1,200 people in the United States each year, according to the National Meningitis Association.
Image: Infant vaccine, via Shutterstock